Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis.
Ramaswamy VV, Abiramalatha T, Bandyopadhyay T, Boyle E, Roehr CC.
Arch Dis Child Fetal Neonatal Ed. 2022 Jul;107(4):393-397. doi: 10.1136/archdischild-2021-322890. Epub 2021 Oct 22.
Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway Versus Brief Tracheal Intubation in Neonates Born Preterm.
Gallup JA, Ndakor SM, Pezzano C, Pinheiro JMB.
J Pediatr. 2023 Mar;254:17-24.e2. doi: 10.1016/j.jpeds.2022.10.009. Epub 2022 Oct 12.
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derrick M, Özkan H, Hulzebos CV, Schmölzer GM, Aiyappan A, Lemyre B, Kuo S, Rajadurai VS, O'Shea J, Biniwale M, Ramanathan R, Kushnir A, Bader D, Thomas MR, Chakraborty M, Buksh MJ, Bhatia R, Sullivan CL, Shinwell ES, Dyson A, Barker DP, Kugelman A, Donovan TJ, Goss KCW, Tauscher MK, Murthy V, Ali SKM, Clark HW, Soll RF, Johnson S, Cheong JLY, Carlin JB, Davis PG; OPTIMIST-A Trial Investigators.
JAMA. 2023 Sep 19;330(11):1054-1063. doi: 10.1001/jama.2023.15694.
Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study).
Corsini I, Rodriguez-Fanjul J, Raimondi F, Boni L, Berardi A, Aldecoa-Bilbao V, Alonso-Ojembarrena A, Ancora G, Aversa S, Beghini R, Meseguer NB, Capasso L, Chesi F, Ciarcià M, Concheiro A, Corvaglia L, Ficial B, Filippi L, Carballal JF, Fusco M, Gatto S, Ginovart G, Gregorio-Hernández R, Lista G, Sánchez-Luna M, Martini S, Massenzi L, Miselli F, Mercadante D, Mosca F, Palacio MT, Perri A, Piano F, Prieto MP, Fernandez LR, Risso FM, Savoia M, Staffler A, Vento G, Dani C.
Trials. 2023 Nov 4;24(1):706. doi: 10.1186/s13063-023-07745-8.
Neonatal surfactant therapy beyond respiratory distress syndrome.
Dargaville PA, Herting E, Soll RF.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101501. doi: 10.1016/j.siny.2023.101501. Epub 2023 Nov 23.
Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta BK, Saha AK, Mukherjee S, Saha B.
Eur J Pediatr. 2020 Aug;179(8):1287-1293. doi: 10.1007/s00431-020-03682-9. Epub 2020 May 27.
Less invasive surfactant administration (LISA): chances and limitations.
Herting E, Härtel C, Göpel W.
Arch Dis Child Fetal Neonatal Ed. 2019 Nov;104(6):F655-F659. doi: 10.1136/archdischild-2018-316557. Epub 2019 Jul 11.
Surfactant delivery by aerosol inhalation - past, present, and future.
Guthrie SO, Pillow JJ, Cummings JJ.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101497. doi: 10.1016/j.siny.2023.101497. Epub 2023 Nov 22.
Inhalable Gene Therapy and the Lung Surfactant Problem.
Kassab G, Doran K, Mo Y, Zheng G.
Nano Lett. 2023 Nov 22;23(22):10099-10102. doi: 10.1021/acs.nanolett.3c03547. Epub 2023 Nov 6.
Surfactant status assessment and personalized therapy for surfactant deficiency or dysfunction.
De Luca D, Loi B, Tingay D, Fiori H, Kingma P, Dellacà R, Autilio C.
Semin Fetal Neonatal Med. 2023 Dec;28(6):101494. doi: 10.1016/j.siny.2023.101494. Epub 2023 Nov 23.
